S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, aims to improve Medicare coverage for innovative medical devices. It establishes a ‘transitional coverage period’ for breakthrough devices – devices designated by the Secretary as offering significant clinical benefits – and streamlines the process for their approval. The bill also requires Medicare to make coverage decisions for these devices within a specific timeframe before the end of the transitional period and provides funding to support the implementation of these changes.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.